Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 721 to 735 of 1553 results for do not do recommendations

  1. Roflumilast for treating chronic obstructive pulmonary disease (TA461)

    Evidence-based recommendations on roflumilast (Daxas) for treating chronic obstructive pulmonary disease in adults with chronic bronchitis.

    Technology appraisal guidance
    Published
    26 July 2017
    View recommendations

    Sections for TA461

  2. Follow-up care after bariatric surgery: Do post-operative lifestyle intervention programmes (exercise, behavioural or dietary) improve weight loss and weight-loss maintenance following bariatric surgery?

    Recommendation ID CG189/03 Question Follow-up care after bariatric surgery: Do post-operative lifestyle intervention...

    Research recommendation
    Published
    30 September 2022

  3. How do financial factors (including incentives, pricing and taxation of food and incentives, and pricing for physical activity opportunities) affect food and physical activity choices?

    Recommendation ID PH35/5 Question How do financial factors (including incentives, pricing and taxation of food and...

    Research recommendation
    Published
    9 June 2015

  4. What symptoms do children, young people, pregnant women and older people with suspected post‑COVID‑19 syndrome present with?

    Recommendation ID NG188/4 Question What symptoms do children, young people, pregnant women and older people with suspected...

    Research recommendation
    Published
    12 November 2021

  5. Dasatinib, nilotinib and high-dose imatinib for treating imatinib-resistant or intolerant chronic myeloid leukaemia (TA425)

    Evidence-based recommendations on dasatinib (Sprycel), nilotinib (Tasigna) and high-dose imatinib (Glivec) for treating imatinib-resistant or intolerant chronic myeloid leukaemia in adults.

    Technology appraisal guidance
    Published
    21 December 2016
    View recommendations

    Sections for TA425

  6. Sorafenib for treating advanced hepatocellular carcinoma (TA474)

    Evidence-based recommendations on sorafenib (Nexavar) for treating advanced hepatocellular carcinoma in adults.

    Technology appraisal guidance
    Published
    6 September 2017
    View recommendations

    Sections for TA474

  7. Which new (previously not researched) primary prevention interventions (that do not include information provision as a component) are effective and cost effective in preventing skin cancer in the UK? What factors influence effectiveness and cost effectiveness?

    Recommendation ID PH32/3 Question Which new (previously not researched) primary prevention interventions (that do not...

    Research recommendation
    Published
    9 June 2015

  8. How do behaviour change techniques lead to change? What are the best methods of testing the relationship between the theories that describe change processes and the effectiveness of interventions in practice?

    Recommendation ID PH49/7 Question How do behaviour change techniques lead to change? What are the best methods of testing...

    Research recommendation
    Published
    9 June 2015

  9. How do different types of training help primary care professionals identify people who are inactive and deliver brief advice? What type of training is most effective?

    Recommendation ID PH44/4 Question How do different types of training help primary care professionals identify people who...

    Research recommendation
    Published
    9 June 2015

  10. How does the duration and frequency of brief advice influence its effectiveness and cost effectiveness? For example, do 'micro interventions' of less than 1–2 minutes have an impact on physical activity?

    Recommendation ID PH44/1 Question How does the duration and frequency of brief advice influence its effectiveness and cost effectiveness

    Research recommendation
    Published
    9 June 2015

  11. How effective are combinations of interventions to deal with domestic violence and abuse in the short, medium and long term? Are the outcomes sustainable and do they have a beneficial effect on quality of life and health in the longer term?

    Recommendation ID PH50/2 Question How effective are combinations of interventions to deal with domestic violence and abuse in the short

    Research recommendation
    Published
    9 June 2015

  12. Prucalopride for the treatment of chronic constipation in women (TA211)

    Evidence-based recommendations on prucalopride (Resolor) for treating chronic constipation in women.

    Technology appraisal guidance
    Published
    15 December 2010
    View recommendations

    Sections for TA211

  13. Inotersen for treating hereditary transthyretin amyloidosis (HST9)

    Evidence-based recommendations on inotersen (Tegsedi) for stage 1 and stage 2 polyneuropathy in adults with hereditary transthyretin amyloidosis.

    Highly specialised technologies guidance
    Published
    22 May 2019
    View recommendations

    Sections for HST9

  14. What organisational mechanisms can ensure interventions to improve the social and emotional wellbeing and 'readiness for school' of vulnerable children aged under 5 years are effectively implemented? How do these differ according to the local context?

    Recommendation ID PH40/6 Question What organisational mechanisms can ensure interventions to improve the social and emotional wellbeing

    Research recommendation
    Published
    9 June 2015

  15. What is the effectiveness and cost effectiveness of interventions to improve indoor air quality at home for people without pre‑existing health conditions?

    Recommendation ID NG149/2 Question What is the effectiveness and cost effectiveness of interventions to improve indoor air quality at...

    Research recommendation
    Published
    10 February 2020